Description: Interview (Q&A) with Charlie Shamieh, Chairman of Gen Re, against the backdrop of the COVID-19 Pandemic and its impact on Re/Insurance

Description: For over a decade, life insurers have been challenged by a low interest rate environment, making it difficult to find investments with adequate yield, manage corporate spreads, and offer competitive products to consumers. While interest rates are still low compared to the early 2000’s, volatility in rates over the past year, during which the 10-year U.S. Treasury rate has increased by nearly 100 basis points, could indicate a longer-term trend of rising rates. What would a rising rate environment imply for life insurance writers? Insurers able to react to interest rate changes with agility can remain relevant in an evolving economy, protecting themselves and their policyholders. This article addresses risks and considerations faced by insurers with respect to in-force retention, pricing and product mix, and reinsurance and mergers & acquisitions.

Description: This article looks at how the underwriting process has transformed from a paper process to become fully online. Not only has the process been digitized, there has been various innovations incorporating technology thus enabling large volume process automation, better customer experience as well as higher closing ratio. Other than improvement on speed and efficiency, various smart solutions are being explored to refine risk management through data mining and analysis of underwriting data.

Description: Interview with global reinsurance leader. View from the top. Provides perspective of macro trends and challenges in developing strategy in a competitive marketplace

Description: This article covers the inaugural edition of Re-News. From Reinsurance News, February 2005. Article from Re-news, February, 2005.

Description: It is with great pleasure that we announce the winner of the “2024 Best Article” in Reinsurance News. Amongst a pool of exceptional articles, the article “What Does the Future of Mortality Look Like?” submitted by Adam Jedynak and Connie Cheng was chosen by the jury as the victorious submission. The article appeared in the June 2024 issue of Reinsurance News. It explores recent shifts in mortality, including post-COVID excess mortality, and looks at the impact of medical advancements and societal changes on mortality.

Description: A jurisdiction’s regulatory regime can make some insurance products capital intensive to write. This can increase incentives for insurers to enter into risk transfer arrangements, such as reinsurance, to support their business and growth objectives.

Description: LEARN is an offering to regulators about reinsurance. This article summarizes a session held for Brazilian health regulators in the fall of 2022.

Description: The global nature of the reinsurance industry has enabled the diversification of risk away from concentration in specific regions to the larger global market. However, record catastrophe losses, inflation stemming from increased interest rates, geopolitical tensions and heightened climate risk are putting operating pressures on insurers and reinsurers. Article discusses the implications.

Description: New digital data known as alternative data is everywhere. Our industry has seen the financial, and hi-tech industries leverage new digital data to expand their key offerings and core services. From the lens of the global life and health industry, new digital data is still searching to be further understood. Risk assessment is a current focus area for using alternative data. A key question is even though risk assessment has always been data-driven, can it now move to the next level with the arrival of this alternative data. Can we use alternative data to make the risk assessment process quicker, cheaper, or faster thereby driving more sales and better conversion rates. It is an exciting time! With the increased adoption of health and well-being apps, data such as physical activity, nutrition, sleep, and mental wellness is now readily available. Expanded data such as digital biomarkers, IoT data, electronic health records and many more can also be accessed. However, how to effectively implement alternative data remains a challenge across the industry. We firmly believe it is, and will continue to be, imperative to take a structured approach to alternative data through a set of key considerations and a framework of principles.